Effects of Hydrotherapy in Children With Cerebral Palsy
Condition(s) studied
Investigational drug(s) / intervention(s)
Intervention Group (water-based and conventional exercise): Patients in the study group will undergo individualized water-based exercises (including standing, balance, weight shifting, breathing exercises, range of motion, stretching, and strengthening exercises) under the supervision of an experienced physiotherapist, 2-3 times per week for six weeks. Additionally, routine conventional exercises will be continued daily for six weeks.
control group (conventional exercise): Patients in the control group will continue passive, active, active-assisted, or resistance-based upper and lower extremity conventional exercises appropriate to their functional level and muscle strength. They will be instructed to perform these exercises 2-3 times per week, with each session lasting no more than 45 minutes, for six weeks.
Study summary
The goal of this observational study is to learn the effects of hydrotherapy in children with cerebral palsy. It aims to answer if hydrotherapy is affective on balance and selective motor control of the children with cerebral palsy.
Eligibility
Primary outcome measure(s)
- Pediatric Balance Scale — six weeks
The Pediatric Balance Scale is a modified version of the Berg Balance Scale that is used to assess functional balance skills during tasks that mimic experiences of everyday living in school-aged children. The scale consists of 14 balance-related test items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56 points.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| GaziosmanpasaTREH | Istanbul | Gaziosmanpasa | Recruiting |
More Gaziosmanpasa Research and Education Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06899035 on ClinicalTrials.gov ↗ ← All trials in Turkey